IARC's mission is to coordinate and conduct research on the causes of human cancer, the mechanisms of carcinogenesis, and to develop scientific strategies for cancer prevention and control. The Agency is involved in both epidemiological and laboratory research and disseminates scientific information through publications, meetings, courses, and fellowships.
03/02/2012 - Each year on 4 February, World Cancer Day, WHO and the International Agency for Research on Cancer (IARC) support the Union for International Cancer Control (UICC) to promote ways to ease the global burden of cancer. Preventing cancer and raising quality of life for cancer patients are recurring themes. WHO and IARC will focus this year on screening and vaccination.
"Together it is possible" is the 2012 theme for World Cancer Day, reinforcing that it is only by every person, organization, and government individually doing their part that the world will be able to reduce premature deaths from cancer and other noncommunicable diseases. Read more
30/01/2012 - The International Agency for Research on Cancer (IARC) coordinates a study entitled “Role of human papillomavirus infection and other co-factors in the aetiology of head and neck cancer in Europe and India” (HPV-AHEAD) that has recently received a grant by the Seventh Framework Programme (FP7) of the European Commission in the Cooperation Work Programme: Health 2011. This proposal will be focused on the elucidation of the role of human papillomavirus (HPV) types and other environmental risk factors in HNC in Europe and India. Overall, the study will provide important insights for the screening, diagnosis, treatment and prophylaxis of HPV-associated HNC in Europe, India and elsewhere. Link to the HPV-AHEAD website
30/01/2012 - The International Agency for Research on Cancer (IARC) is the coordinating centre of “Epidemiological study to quantify risks for paediatric computerized tomography and to optimize doses (EPI-CT)", an international project supported by the European Union. The EPI-CT study uses cohort data from nine European countries: Belgium, Denmark, France, Germany, the Netherlands, Norway, Spain, Sweden, and the United Kingdom: 1 million patients will be enrolled. The study aims to evaluate the factors associated with the use of paediatric CT scans, to build evidence to understand risks vs benefits of CT procedures and to define strategies for dose reduction.
A dedicated website, http://epi-ct.iarc.fr is the public interface of the study. Visit EPI-CT website
